CAR T-cell therapy, SEM

CAR T-cell therapy, SEM

C038/8806 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.0MB

Downloadable file size: 4.3MB

Price image Pricing

Please login to use the price calculator


Credit: STEVE GSCHMEISSNER/SCIENCE PHOTO LIBRARY

Caption: T-cells and prostate cancer cells. Composite coloured scanning electron micrograph (SEM) of T-cells and prostate cancer cells (pink). T-cells are a component of the body's immune system. CAR T-cell therapy takes T-cells from a cancer patient's blood and modifies them to recognize a specific protein found on patient's tumor cells. When reintroduced to the patient the T-cells find and destroy the tumour cells. The newest form of CAR T-cell therapy, now in clinical trials, uses "memory" T-cells which remain in the body after attacking the cancer. The hope is that memory T-cells may provide an active reservoir of cancer-killing cells capable of stopping further tumours.

Release details: Model release not required. Property release not required.

Keywords: abnormal, cancer cell, cancerous, car, car t cell therapy, car-t, cell, cell biology, cells, chimeric antigen receptor, clinical trial, coloured, condition, disease, disorder, false-coloured, growth, histopathological, histopathology, malignancy, malignant, medical, medicine, memory t cell, no-one, nobody, oncological, oncology, prostate cancer, research, scanning electron micrograph, scanning electron microscope, sem, t-cell, therapy, treatment, tumor, tumour, unhealthy

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.